Dapagliflozin Comparable with Empagliflozin for Long-Term Kidney Outcomes in T2D
Drug Topics
JANUARY 25, 2025
Among a population of patients with type 2 diabetes, researchers assessed the similarities and differences between SGLT2 inhibitors.
Sat.Jan 25, 2025
467 
Radiotherapy Benefits Overall Survival in Older Patients With Early-Stage Triple Negative Breast Cancer
Pharmacy Times
JANUARY 25, 2025
Presence of comorbidities in older patients with breast cancer complicates treatment decisions.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Wegovy maker Novo Nordisk rebuked by watchdog over failure to disclose payments to UK health groups
The Guardian - Pharmaceutical Industry
JANUARY 25, 2025
Danish drug giant found to have failed to accurately report spending even after admitting to errors The pharmaceutical watchdog has reprimanded Wegovy maker Novo Nordisk for failing to correctly disclose dozens of payments to the UK health sector as it sought to boost sales of its slimming drugs. The Danish drug giant Europes most valuable listed company systematically misreported, under-reported or did not disclose funding given over seven years to pharmacy firms, obesity charities, training
Tucatinib in Combination With Trastuzumab Demonstrates Safety, Efficacy in Patients With HER2-Mutated Breast Cancer
Pharmacy Times
JANUARY 25, 2025
Tucatinib is an oral HER2-targeting tyrosine kinase inhibitor that was approved by the FDA in 2020.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
‘Skinny jabs’ are turning slimmers teetotal – and drinks companies are feeling the loss
The Guardian - Pharmaceutical Industry
JANUARY 25, 2025
As the public rejoice at shedding weight, the likes of Wegovy seem to be controlling other bad habits in particular drinking to excess My alcohol intake has plummeted, says Hannah. Since taking Wegovy I hardly ever crave a drink when I get home. When I used to go out with friends, I was nearly always the last one standing; now Im leaving two hours before closing.
Are you affected by the Trump administration’s pause on health communications, science meetings, and reviews?
STAT
JANUARY 25, 2025
The Trump administration has put a temporary freeze on many federal health and science agency affairs. In response, agencies have prohibited employees from communicating with the public, attending many public meetings, and submitting at least some scientific research papers.
Let's personalize your content